Inventor · disambiguated record
Takeshi Imanishi
Also filed as: IMANISHI TAKESHI
21 granted patents·4 pending applications·4,385 citations·filing 1990–2024
97Inventor score
Files withIMANISHI TAKESHI4TAKESHI IMANISHI4DAIICHI SANKYO CO LTD3RIKEN GENESIS CO LTD2TAISHO PHARMACEUTICAL CO LTD2
Top patents by PatentIndex Score
25 records- 0198US7314923B2Nucleoside and oligonucleotide analoguesDAIICHI SANKYO CO LTD·Filed 2003·Granted Jan 1, 2008·214 cites·12 claims
- 0298US6770748B2Bicyclonucleoside and oligonucleotide analogueIMANISHI TAKESHI·Filed 2001·Granted Aug 3, 2004·1k cites·5 claims
- 0397US7427672B2Artificial nucleic acids of n-o bond crosslinkage typeIMANISHI TAKESHI·Filed 2004·Granted Sep 23, 2008·868 cites·20 claims
- 0497US7335765B2Nucleoside and oligonucleotide analoguesDAIICHI SANKYO CO LTD·Filed 2001·Granted Feb 26, 2008·174 cites·60 claims
- 0597US6268490B1Bicyclonucleoside and oligonucleotide analoguesTAKESHI IMANISHI·Filed 1998·Granted Jul 31, 2001·1.3k cites·8 claims
- 0697US6043060ANucleotide analoguesFiled 1997·Granted Mar 28, 2000·215 cites·3 claims
- 0796US7816333B2Oligonucleotide analogues and methods utilizing the sameDAIICHI SANKYO CO LTD·Filed 2007·Granted Oct 19, 2010·43 cites·19 claims
- 0895US7217805B2Bicyclonucleoside analoguesSANKYO CO·Filed 2002·Granted May 15, 2007·85 cites·16 claims
- 0995US7053199B2Nucleoside analogs and oligonucleotide derivatives containing these analogsIMANISHI TAKESHI·Filed 2001·Granted May 30, 2006·139 cites·10 claims
- 1092USRE44779EBicyclonucleoside and oligonucleotide analoguesIMANISHI TAKESHI·Filed 1998·Granted Feb 25, 2014·178 cites·32 claims
- 1191US8957201B2Oligonucleotide analogues and methods utilizing the sameKANEKO MASAKATSU·Filed 2010·Granted Feb 17, 2015·23 cites·13 claims
- 1290US7994145B2Bicyclonucleoside analoguesTAKESHI IMANISHI·Filed 2007·Granted Aug 9, 2011·17 cites·16 claims
- 1383US7615619B2Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereofTAKESHI IMANISHI·Filed 2003·Granted Nov 10, 2009·21 cites·34 claims
- 1469US9127280B2Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredientOBIKA SATOSHI·Filed 2011·Granted Sep 8, 2015·3 cites·10 claims
- 1557US2025059227A1Artificial nucleic acid, method for producing same, and use of sameRIKEN GENESIS CO LTD·Filed 2024·Application pending·0 cites
- 1654US5189211ASulfonamide derivativesTAISHO PHARMACEUTICAL CO LTD·Filed 1991·Granted Feb 23, 1993·12 cites·3 claims
- 1749US5414843AMethod and system for generating a project schedule using weighted work processesHITACHI LTD·Filed 1994·Granted May 9, 1995·65 cites·7 claims
- 1847US12421272B2Artificial nucleic acid, production method therefor, and use thereofSYSMEX CORP·Filed 2021·Granted Sep 23, 2025·0 cites·14 claims
- 1947US8680260B218F-labeled azide compound, reagent for 18F-labeling and method for 18F-labeling of alkyne compound using sameWATANABE YASUYOSHI·Filed 2010·Granted Mar 25, 2014·0 cites·6 claims
- 2047US2023257413A1Artificial nucleic acid, method for producing same, and use thereofRIKEN GENESIS CO LTD·Filed 2023·Application pending·0 cites
- 2147US2005176941A1Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereofFiled 2003·Application pending·0 cites
- 2246US5028716A3,5-diamino-1,2,4-triazole derivativesTAISHO PHARMACEUTICAL CO LTD·Filed 1990·Granted Jul 2, 1991·3 cites·8 claims
- 2341US2005059617A1Novel anitsense oligonucleotide derivatives against to hepatitis c virusTAKESHI IMANISHI·Filed 2002·Application pending·0 cites
- 2435US10253360B2BNA clamp methodBNA INC·Filed 2013·Granted Apr 9, 2019·0 cites·21 claims
- 2525US5747451APeptide derivatives having binding activity to modified low density lipoproteinPROTEIN ENGINEERING RESEARCH I·Filed 1995·Granted May 5, 1998·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Takeshi Imanishi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →